We are live on ! Find out more
BIOC

Biocept, Inc.

Delisted

BIOC was delisted on the 24th of October, 2023.

17 hedge funds and large institutions have $2.67M invested in Biocept, Inc. in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

42% more funds holding

Funds holding: 1217 (+5)

47% less capital invested

Capital invested by funds: $5.04M → $2.67M (-$2.37M)

60% less call options, than puts

Call options by funds: $36K | Put options by funds: $91K

Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
Closed
3
Calls
$36K
Puts
$91K
Net Calls
-$55K
Net Calls Change
-$26K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$633K +$62.5K +1 +11%
BIT
2
BlackRock Institutional Trust
California
$392K +$375K +6 New
GBA
3
Garrison Bradford & Associates
New York
$315K
Creative Planning
4
Creative Planning
Kansas
$199K +$188K +3 New
Bank of America
5
Bank of America
North Carolina
$189K +$62.5K +1 +50%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$187K
Morgan Stanley
7
Morgan Stanley
New York
$152K
BFA
8
BlackRock Fund Advisors
California
$100K
CC
9
Callan Capital
California
$87K
VKH
10
Virtu KCG Holdings
New York
$50K +$62.5K +1 New
AL
11
Airain Ltd
Guernsey
$48K +$62.5K +1 New
Northern Trust
12
Northern Trust
Illinois
$47K
HighTower Advisors
13
HighTower Advisors
Illinois
$45K +$62.5K +1 New
Barclays
14
Barclays
United Kingdom
$43K +$62.5K +1 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$42K +$62.5K +1 New
Citadel Advisors
16
Citadel Advisors
Florida
$41K +$62.5K +1 New
SCM
17
Sterneck Capital Management
Missouri
$32K
William Blair & Company
18
William Blair & Company
Illinois
$23K
UBS Group
19
UBS Group
Switzerland
$16K
Citigroup
20
Citigroup
New York
$12K
BIM
21
BlackRock Investment Management
Delaware
$6K
EWM
22
Edge Wealth Management
New York
$5K
MFS
23
MSI Financial Services
Massachusetts
$3K
HR
24
Howe & Rusling
New York
$2K
TRCT
25
Tower Research Capital (TRC)
New York
$1K

BIOC Hedge Fund Activity: Q3 2015 in Review

17 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2015, worth a combined $2.67M — down 47% from $5.04M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIOC positions and 3 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Institutional Trust, opening a new position worth an estimated $375K. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $1.8M sold.

  • 17 institutional investors held Biocept, Inc. (BIOC) as of Q3 2015, up from 12 in Q2 2015.
  • Funds reported $2.67M of Biocept, Inc. stock for Q3 2015, down 47% quarter-over-quarter.
  • 8 funds opened new Biocept, Inc. positions in Q3 2015 and 3 closed out, a net change of +5 holders.
  • The largest Biocept, Inc. buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $375K added.
  • The largest Biocept, Inc. seller in Q3 2015 was Kennedy Capital Management, an estimated $1.8M sold.

Based on aggregated 13F filings for Q3 2015.